CYTOKINE-MEDIATED PATHOPHYSIOLOGY IN FANCONI ANEMIA
范可尼贫血中细胞因子介导的病理生理学
基本信息
- 批准号:6211564
- 负责人:
- 金额:$ 4.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-21 至
- 项目状态:未结题
- 来源:
- 关键词:adrenocorticotropic hormone antisense nucleic acid apoptosis cellular pathology congenital aplastic anemia disease /disorder model endocrine disorder endocrinology follicle stimulating hormone gene mutation genetically modified animals hematopoietic stem cells hormone biosynthesis human tissue hypothalamus interferon gamma interleukin 6 laboratory mouse luteinizing hormone oligonucleotides polymerase chain reaction somatotropin thyrotropin tissue /cell culture tumor necrosis factor alpha
项目摘要
Fanconi anemia (FA) is an autosomal recessive disorder characterized by cellular hypersensitivity to DNA crosslinking agents such as mitomycin C (MMC) and diepoxybutane (DEB) (Auerbach 1993), bone marrow (BM) failure, diverse congenital anomalies, and a marked increased in the incidence of malignancies. Eight complementation groups (FA-A through FA-H) have been identified. The human genes defected in the FA-C, FA- A FA-G groups were recently cloned. Fancc-deficient mice have been created by targeted mutations of the murine Fancc gene. Cells from France -/- mice showed hypersensitivity to MMC and DEB. Surprisingly, however, no gross hematologic defects or congenital anomalies were detected, although the homozygous mice showed decreased fertility. Evidence has been collected indicating that certain cytokines are involved in Fanconi anemia. TNF-alpha and IFN-gamma are inhibitory cytokines that can induced deregulated. Progenitor growth and apoptosis in Fancc-/- hematopoietic progenitor cells (HPC). FANCC transgene protected HPC FANCC transgene protected HPC from Fas-mediated apoptosis. IL-6, TNF-alpha and IFN-gamma, among others, are known to mediate immune-neuro-endocrine interactions. More recently, multiple endocrine abnormalities were discovered in FA patients, including deficiencies in growth hormone, thyroid and gonads function. We hypothesize that the endocrine abnormalities be due to aberrant response to cytokines, particularly TNF-alpha and IFN-gamma, in the endocrine glands. The proposed project will use Fancc-deficient mice and cell lines derived from endocrine glands, along with certain cytokines, to test this hypothesis.
范可尼贫血(FA)是一种常染色体隐性遗传病,其特征是细胞对丝裂霉素 C(MMC)和二环氧丁烷(DEB)等 DNA 交联剂过敏(Auerbach 1993)、骨髓(BM)衰竭、多种先天性异常以及恶性肿瘤发病率显着增加。已确定八个互补组(FA-A 至 FA-H)。 FA-C、FA-A、FA-G 组中缺陷的人类基因最近被克隆。 Fancc 缺陷小鼠是通过小鼠 Fancc 基因的定向突变而产生的。来自 France -/- 小鼠的细胞对 MMC 和 DEB 表现出超敏反应。然而,令人惊讶的是,尽管纯合子小鼠表现出生育能力下降,但没有检测到明显的血液学缺陷或先天性异常。已收集的证据表明某些细胞因子与范可尼贫血有关。 TNF-α 和 IFN-γ 是抑制性细胞因子,可诱导失调。 Fancc-/- 造血祖细胞 (HPC) 中的祖细胞生长和凋亡。 FANCC 转基因保护 HPC FANCC 转基因保护 HPC 免受 Fas 介导的细胞凋亡。已知 IL-6、TNF-α 和 IFN-γ 等可介导免疫-神经-内分泌相互作用。最近,在 FA 患者中发现了多种内分泌异常,包括生长激素、甲状腺和性腺功能缺陷。我们假设内分泌异常是由于内分泌腺对细胞因子,特别是 TNF-α 和 IFN-γ 的异常反应所致。拟议的项目将使用 Fancc 缺陷小鼠和源自内分泌腺的细胞系以及某些细胞因子来检验这一假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MING CHEN其他文献
MING CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MING CHEN', 18)}}的其他基金
Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology
在小鼠中进行大量染色体缺失以推进精准肿瘤学
- 批准号:
10445187 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
开发一种治疗致命性神经内分泌前列腺癌的新型组合疗法
- 批准号:
10518805 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
开发一种针对致命性神经内分泌前列腺癌的新型组合疗法
- 批准号:
10664011 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology
在小鼠中进行大量染色体缺失以推进精准肿瘤学
- 批准号:
10579292 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
靶向致命性 RB1 缺陷型前列腺癌中的铁死亡
- 批准号:
10413399 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
靶向致命性 RB1 缺陷型前列腺癌中的铁死亡
- 批准号:
10588173 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
CYTOKINE-MEDIATED PATHOPHYSIOLOGY IN FANCONI ANEMIA
范可尼贫血中细胞因子介导的病理生理学
- 批准号:
6526631 - 财政年份:2002
- 资助金额:
$ 4.63万 - 项目类别:
CYTOKINE-MEDIATED PATHOPHYSIOLOGY IN FANCONI ANEMIA
范可尼贫血中细胞因子介导的病理生理学
- 批准号:
6402758 - 财政年份:2001
- 资助金额:
$ 4.63万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 4.63万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 4.63万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)